← X-Energy, Inc. Class A Common Stock overview

X-Energy, Inc. Class A Common Stock vs BWX: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

X-Energy, Inc. Class A Common Stock (XE)

Q3 2026
▲3▼1

X-Energy's Q3: Regulatory Setback, Then Capital-Light Pivot and Funding Wins

  • First Reactor Delayed to 2027 Regulators failed to approve X-Energy's reactor design, pushing its first Amazon project to 2027. Jefferies downgraded the stock, cut its price target from $30 to $22, and shares fell 19.2% in a week.

    This regulatory delay and downgrade were the main negative force on the stock this quarter.

  • Shift to Capital-Light Licensing and Fuel X-Energy pivoted to licensing its Xe-100 reactor and selling TRISO-X fuel. It won the first U.S. commercial advanced-fuel license and an $11 million Tennessee grant, reducing the need to build and own reactors.

    This strategic shift offers a new revenue path without heavy capital spending.

  • Government Backing and New Funding X-Energy joined Trump's AI-nuclear program and the Prometheus project, gained up to $1 billion more DOE funding (total $2.115 billion), and attracted a Peter Thiel stake. It has $1.9 billion cash and zero debt.

    Government support and fresh capital strengthen X-Energy's financial position and credibility.

  • Ark Invest Buys the Dip Ark Invest bought $15.4 million of X-Energy stock after the price drop, signaling confidence in the company's long-term prospects despite the recent setback.

    A notable investor purchase can support sentiment and signal belief in the company's future.

August 2026
▲4

X-Energy's AI power deals and $1B DOE boost drive growth story

  • Joins Trump AI-nuclear program X-Energy joined a $200 million Trump administration effort with Microsoft and Nvidia to speed nuclear reactors for AI data centers. This puts XE at the center of a national push to power AI, boosting demand for its reactors and lifting the stock.

    This is a new, concrete government program that directly benefits XE's core business and investor perception.

  • Tier 1 partner in $60M Prometheus AI-nuclear project X-Energy became a Tier 1 partner in the Prometheus project, providing $10 million and its Xe-100 reactor and TRISO-X fuel designs. The AI-driven research aims to accelerate commercial deployment across its 11 GW pipeline, a clear positive for future revenue.

    This is a new, specific partnership that advances XE's technology and pipeline, directly supporting the stock.

  • Up to $1B extra DOE funding and strong cash X-Energy announced up to $1 billion more from the DOE for its ARDP agreement, raising the DOE cost share to $2.115 billion. With $1.9 billion in cash, zero debt, and NRC permit expected by Q1 2027, the company is well-funded to execute.

    This is a new, material funding update that strengthens XE's balance sheet and reduces financing risk.

  • Thiel bet and AI power bottleneck highlight Peter Thiel's fund disclosed a $3.7 million stake in X-Energy as part of a $418 million bet on AI's power bottleneck. Amazon's ~$500 million investment and XE's 11.5 GW pipeline underscore its role in solving AI's energy needs, drawing investor attention.

    This is a new, high-profile endorsement that validates XE's demand thesis and could attract more investors.

Latest
▲4

X-Energy's AI power deals and $1B DOE boost drive growth story

  • Joins Trump AI-nuclear program X-Energy joined a $200 million Trump administration effort with Microsoft and Nvidia to speed nuclear reactors for AI data centers. This puts XE at the center of a national push to power AI, boosting demand for its reactors and lifting the stock.

    This is a new, concrete government program that directly benefits XE's core business and investor perception.

  • Tier 1 partner in $60M Prometheus AI-nuclear project X-Energy became a Tier 1 partner in the Prometheus project, providing $10 million and its Xe-100 reactor and TRISO-X fuel designs. The AI-driven research aims to accelerate commercial deployment across its 11 GW pipeline, a clear positive for future revenue.

    This is a new, specific partnership that advances XE's technology and pipeline, directly supporting the stock.

  • Up to $1B extra DOE funding and strong cash X-Energy announced up to $1 billion more from the DOE for its ARDP agreement, raising the DOE cost share to $2.115 billion. With $1.9 billion in cash, zero debt, and NRC permit expected by Q1 2027, the company is well-funded to execute.

    This is a new, material funding update that strengthens XE's balance sheet and reduces financing risk.

  • Thiel bet and AI power bottleneck highlight Peter Thiel's fund disclosed a $3.7 million stake in X-Energy as part of a $418 million bet on AI's power bottleneck. Amazon's ~$500 million investment and XE's 11.5 GW pipeline underscore its role in solving AI's energy needs, drawing investor attention.

    This is a new, high-profile endorsement that validates XE's demand thesis and could attract more investors.

July 2026
▲3▼1

X-Energy's capital-light nuclear fuel strategy gains traction after delay-driven selloff

  • First reactor delayed to 2027; Jefferies downgrade X-Energy's first Amazon reactor slipped to 2027 because U.S. regulators haven't approved its reactor design. Jefferies downgraded the stock and cut its price target from $30 to $22. The stock fell 19.2% that week, a real setback for a pre-revenue company.

    This is the main negative force this period, explaining why the stock sold off and remains under pressure.

  • Capital-light licensing and fuel-sales model X-Energy is shifting to licensing its Xe-100 reactor design and selling TRISO-X fuel instead of building plants itself. This avoids huge construction costs and creates recurring fuel revenue over each reactor's 60-year life. Its fuel facility got the first U.S. license for commercial advanced fuel production.

    This new strategy is the core reason investors can still see long-term value despite the delay.

  • Tennessee $11M grant expands fuel campus TRISO-X won an $11 million Tennessee grant to expand its Oak Ridge fuel campus, adding TX-2 and TX-L facilities. Together they could fuel about 55 Xe-100 reactors, nearly 4.5 gigawatts. This directly supports future reactor demand and shows government backing.

    New government funding signals real progress on the fuel side, a fresh positive catalyst.

  • Ark Invest buys the dip, adding $15.4M Cathie Wood's Ark Invest bought more X-Energy shares on the dip, including a $15.4 million purchase the week of July 13. A well-known fund showing conviction can support the stock, though it doesn't change the company's delayed project timeline.

    A notable investor's buying is a fresh signal of confidence, though it's a sentiment boost rather than a fundamental fix.

▲3▼1

X-Energy's capital-light nuclear fuel strategy gains traction after delay-driven selloff

  • First reactor delayed to 2027; Jefferies downgrade X-Energy's first Amazon reactor slipped to 2027 because U.S. regulators haven't approved its reactor design. Jefferies downgraded the stock and cut its price target from $30 to $22. The stock fell 19.2% that week, a real setback for a pre-revenue company.

    This is the main negative force this period, explaining why the stock sold off and remains under pressure.

  • Capital-light licensing and fuel-sales model X-Energy is shifting to licensing its Xe-100 reactor design and selling TRISO-X fuel instead of building plants itself. This avoids huge construction costs and creates recurring fuel revenue over each reactor's 60-year life. Its fuel facility got the first U.S. license for commercial advanced fuel production.

    This new strategy is the core reason investors can still see long-term value despite the delay.

  • Tennessee $11M grant expands fuel campus TRISO-X won an $11 million Tennessee grant to expand its Oak Ridge fuel campus, adding TX-2 and TX-L facilities. Together they could fuel about 55 Xe-100 reactors, nearly 4.5 gigawatts. This directly supports future reactor demand and shows government backing.

    New government funding signals real progress on the fuel side, a fresh positive catalyst.

  • Ark Invest buys the dip, adding $15.4M Cathie Wood's Ark Invest bought more X-Energy shares on the dip, including a $15.4 million purchase the week of July 13. A well-known fund showing conviction can support the stock, though it doesn't change the company's delayed project timeline.

    A notable investor's buying is a fresh signal of confidence, though it's a sentiment boost rather than a fundamental fix.

BWX Technologies Inc (BWXT)

Q3 2026
▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

  • Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.

    This is a new, major demand driver that expands BWXT's addressable market.

  • Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.

    This is the core financial update that directly lifts investor expectations and the stock price.

  • Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.

    This strategic move frees up capital and refocuses the company on higher-growth areas.

  • Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.

    A record backlog is a key indicator of future sales and earnings power.

August 2026
▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

  • Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.

    This is a new, major demand driver that expands BWXT's addressable market.

  • Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.

    This is the core financial update that directly lifts investor expectations and the stock price.

  • Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.

    This strategic move frees up capital and refocuses the company on higher-growth areas.

  • Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.

    A record backlog is a key indicator of future sales and earnings power.

Latest
▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

  • Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.

    This is a new, major demand driver that expands BWXT's addressable market.

  • Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.

    This is the core financial update that directly lifts investor expectations and the stock price.

  • Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.

    This strategic move frees up capital and refocuses the company on higher-growth areas.

  • Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.

    A record backlog is a key indicator of future sales and earnings power.

Q2 2026
▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

  • mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.

    New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.

  • Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.

    Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.

  • Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.

    New analyst actions reflect improving sentiment and can influence short-term demand for the stock.

  • Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.

    New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

June 2026
▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

  • mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.

    New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.

  • Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.

    Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.

  • Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.

    New analyst actions reflect improving sentiment and can influence short-term demand for the stock.

  • Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.

    New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

  • mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.

    New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.

  • Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.

    Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.

  • Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.

    New analyst actions reflect improving sentiment and can influence short-term demand for the stock.

  • Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.

    New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

© 2026 MarketIVWhy